Robert I. Haddad

Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

Robert L. Ferris, George R. Blumenschein, Jérôme Fayette et al. · New England Journal of Medicine · 2016 · 5.1K citations · Full text

Medicine, Oncology, Metastasis +5

Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer

Marshall R. Posner, Diáne Hershock, C. Blajman et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Chemotherapy +8

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

David G. Pfister, Sharon Spencer, David J. Adelstein et al. · Journal of the National Comprehensive Cancer Network · 2020 · 1.4K citations

Medicine, Oncology, Otolaryngology +17

Recent Advances in Head and Neck Cancer

Robert I. Haddad, Dong M. Shin · New England Journal of Medicine · 2008 · 926 citations

Medicine, Cancer Biology, Oncology +13

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort

Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta et al. · Journal of Clinical Oncology · 2016 · 859 citations · Full text

Medicine, Oncology, Pharmacology +17